Skip to main content
Premium Trial:

Request an Annual Quote

NuSep Extends Closing Date on Share Purchase Offer

NEW YORK (GenomeWeb News) – Australian bioseparations firm NuSep said on Monday it has extended the closing date of its current share purchase offer to Aug. 26.

It added that to date, it has received about A$1.3 million ($1.4 million) of a targeted amount of A$2.1 million. The offering, which was announced in July and which had an original closing date of July 29, had been extended previously to Aug. 15.

The company is offering 21 million shares of iys stock at A$.10 per share, and in a prospectus said that if A$1.5 million is raised from the offering, A$200,000 would go toward the marketing of gels and IQ software, and A$1.3 million will be invested into a plasma project involving SingPharm in Singapore, which is using NuSep technology to manufacture therapeutic plasma products, and for general corporate purposes.

If A$2.1 million is raised, A$500,000 will be used for marketing of gel products and IQ software with the rest going toward the Singapore plasma project and general corporate purposes.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.